Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial

MLA

Jonathan D. C. Ross, et al. “Intravaginal Lactic Acid Gel versus Oral Metronidazole for Treating Women with Recurrent Bacterial Vaginosis: The VITA Randomised Controlled Trial.” BMC Women’s Health, vol. 23, no. 1, May 2023, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12905-023-02303-5.

APA

Jonathan D. C. Ross, Clare Brittain, Jocelyn Anstey Watkins, Joe Kai, Miruna David, Mara Ozolins, Louise Jackson, Zainab Abdali, Trish M. Hepburn, Frances Griffiths, Alan Montgomery, Jane Daniels, Alice Manley, Gillian Dean, & Lindsay K. Armstrong-Buisseret. (2023). Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial. BMC Women’s Health, 23(1), 1–11. https://doi.org/10.1186/s12905-023-02303-5

Chicago

Jonathan D. C. Ross, Clare Brittain, Jocelyn Anstey Watkins, Joe Kai, Miruna David, Mara Ozolins, Louise Jackson, et al. 2023. “Intravaginal Lactic Acid Gel versus Oral Metronidazole for Treating Women with Recurrent Bacterial Vaginosis: The VITA Randomised Controlled Trial.” BMC Women’s Health 23 (1): 1–11. doi:10.1186/s12905-023-02303-5.